GenoBank.io

GenoBank.io operates a platform for patient-owned biosamples and biodata. Physical DNA samples are cryptographically linked to blockchain metadata so that actor, owner, consent status and derived datasets can be tracked, and users store resulting genomic files in a personal "GenoVault" that they can share, license for revenue, or revoke access to. The company's stated origin product was a privacy-preserving direct-to-consumer DNA kit that anonymized DNA data using blockchain and differential privacy while keeping datasets in an encrypted DNA wallet accessible only to the user.

The technical stack combines a blockchain notary service for e-consent and metadata decryption keys, BioNFT consent tokens, an on-demand BioLinux environment with preloaded bioinformatics libraries, double SHA-256 encryption, and Story Protocol IP assets used to register and license genomic intellectual property. A BioFS/BioFS-NODE storage and data-exchange layer is positioned to connect genomic data suppliers such as labs, biobanks, patients and independent researchers with builders of biological foundation models, adding provenance, rights clearance and micropayment ("biodata dividend") mechanisms with Shapley-value attribution. The company also offers AI-assisted bioinformatics, including OpenCRAVAT integration for variant annotation and an MCP server that allows Anthropic's Claude to read a user's vault after wallet or Google sign-in.

Stated company milestones include deployment of BioNFT consent tokens across 33 international laboratories and four U.S. laboratories, a BiodataRouter smart contract orchestrating 47 whole-exome analyses, and an x402 payment protocol for gasless USDC transfers in healthcare.

Founding story

Daniel Uribe is identified as founder and CEO and is described as working in blockchain genomics since 2018.

Business model

The platform positions genomic data as a licensable digital asset: patients hold biosamples and derived files as tokenized BioIP, researchers and AI model builders obtain programmable licenses to that data, and contributors receive compensation when their data is used. Earlier materials also describe a consumer DNA kit sold under GenoBank.io branding, including a co-branded white-label kit for a clinic chain.

Sources describe licensing of patient-owned genomic datasets under programmable licenses and micropayment settlement to data contributors, plus DNA kit sales, but do not disclose pricing or revenue figures.

Traction

The website reports more than 7,000 GenoVaults, over 150 research partnerships, and more than $6.9M in stated BioIP value. Earlier materials cite a beta with RIO, a chain of health clinics serving roughly 1,000 patients a month across seven clinics beginning in Q4 2019, a waiting list of more than 400 users, and BioNFT consent tokens deployed at 33 international and four U.S. laboratories.

Latest developments

In late 2025 the company published its BioFS-NODE hackathon project positioning genomic data as training input for biological foundation models, presented an integration of World ID proof-of-personhood with its Biowallet decentralized laboratory ID at the World Network conference, and launched an MCP server connector allowing Claude to read user vaults.